Bengaluru, India

Lakshindra Chetia

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aquinox Pharmaceuticals (Canada) Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakshindra Chetia. Retrieved from https://idiyas.com/inventor/lakshindra-chetia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lakshindra Chetia: Innovator in Pharmaceutical Chemistry

Introduction

Lakshindra Chetia is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex chemical compounds. His work is characterized by a focus on innovative methods that enhance the development of therapeutic agents.

Latest Patents

Lakshindra holds a patent for the "Synthesis of a substituted indene derivative." This invention is directed to methods of preparing AQX-1125, which has a specific chemical formula. Additionally, the patent covers intermediates utilized in the methods of preparing AQX-1125, showcasing his expertise in chemical synthesis.

Career Highlights

Lakshindra is currently associated with Aquinox Pharmaceuticals (Canada) Inc., where he applies his knowledge and skills in drug development. His work at the company emphasizes the importance of innovative approaches in creating effective pharmaceutical solutions.

Collaborations

He has collaborated with notable colleagues, including Curtis Harwig and Jeyaprakashnarayanan Seenisamy. These collaborations highlight the importance of teamwork in advancing research and development in the pharmaceutical industry.

Conclusion

Lakshindra Chetia's contributions to pharmaceutical chemistry through his innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…